CTRL-labs is developing an electromyography-based armband that reads nerve signals that travel from the brain to the fingers. The signals are translated into desired intentions, enabling thought-to-text and moving objects. The company uses neuroanatomy to identify individual muscle fibers and reconstruct the activity of individual neurons that control those muscle fibers.
CTRL-labs’ armband is lined with electrodes that measure electrical pulses along the neurons in the arm that are transmitting signals from the brain to the muscles. These signals coming from the neurons are intentions to move and can be detected before the person moves or even if they do not move.
CEO and co-founder Thomas Reardon previously founded Avegadro and worked at Microsoft. Reardon co-founded the Worldwide Web Consortium and was an architect of XML and CSS. Reardon earned a PhD in Neuroscience from Columbia University.Co-founder and CSO Patrick Kaifosh received his PhD in Neuroscience from Columbia University, was a Co-Founder & Board Member at Geomechanica, Inc., and a Howard Hughes Medical Institute Fellow. Co-founder Tim Machado earned his PhD in Neuroscience from Columbia University, was a Graduate Fellow of the National Science Foundation and won the 2015 Kavli Award for Distinguished Research in Neuroscience.
Patrick Kaifosh, PhD
CSO & Co-Founder
Thomas Reardon, PhD
CEO & Co-Founder
Timothy Machado, PhD
Advisor & Co-Founder
I tried the wristband that lets you control computers with your brain
Documentaries, videos and podcasts
- NeuralinkNanobiotechnology company developing brain-machine interface to connect humans and computers based in San Francisco, California.
- North Inc.Wearable device company founded in 2012 based in Kitchener, Ontario, Canada. The company was previously called Thalmic and changed their name to North in 2018.
- KernelKernel is a neuroscience and engineering company founded in 2016, based in Los Angeles. Kernel is developing neuroprosthetics that mimic or assist brain functions for patients with neurological and degenerative brain diseases. In the long term Kernel plans to develop less invasive brain implants that can augment human intelligence.